Selecta Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Selecta Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Selecta Biosciences Inc
Rating: 0.86608325
Author: Trendlyne DVM scores

about

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages ...

7.49 -0.11 (-1.45%)

51.89% Fall from 52W High

45,216

XNAS Volume

XNAS 28 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

4.8 / 100

Technically Bearish

29.8 / 100

No estimates available

Selecta Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Selecta Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages ...

51.89% Fall from 52W High

SWOT Analysis

Selecta Biosciences Inc Live Price Chart